Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 56, Issue 7, Pages 3102-3114Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm400195y
Keywords
-
Categories
Funding
- National Natural Science Foundation of China [91213302, 20932003, 21272102]
- Ministry of Science and Technology of China [2012ZX09504001-003]
- Fundamental Research Funds for the Central Universities [lzujbky-2011-86]
- Ministry of Education
Ask authors/readers for more resources
Recently we reported the synthesis and structure activity study of endomorphin-1 (EM-1) analogues containing novel, unnatural alpha-methylene-beta-aminopropanoic acids (Map). In the present study, we describe new EM-1 analogues containing Dmt(1), (R/S)-beta Pro(2), and (ph)Map(4)/(2-furyl)Map(4). All of the analogues showed a high affinity for the mu-opioid receptor (MOR) and increased stability in mouse brain homogenates. Of the new compounds, Dmt(1)-(R)-beta Pro(2)-Trp(3)-(2-furyl)Map(4) (analogue 12) displayed the highest affinity toward MOR, in the picomolar range (K-i(mu) = 3.72 pM). Forskolin-induced cAMP accumulation assays indicated that this analogue displayed an extremely high agonistic potency, in the subpicomolar range (EC50 = 0.0421 pM, E-max = 99.5%). This compound also displayed stronger in vivo antinociceptive activity after iv administration when compared to morphine in the tail-flick test, which indicates that this analogue was able to cross the blood-brain barrier.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available